Rankings
▼
Calendar
EOLS FY 2017 Earnings — Evolus, Inc. Revenue & Financial Results | Market Cap Arena
EOLS
Evolus, Inc.
$338M
FY 2017 Earnings
Healthcare
Drug Manufacturers - Specialty & Generic
Income Statement
Revenue
$0
Gross Profit
-$218,000
Operating Income
-$12M
Net Income
-$4M
EPS (Diluted)
$-0.19
Cash Flow
Operating Cash Flow
-$13M
Free Cash Flow
-$13M
Stock-Based Comp.
$586,000
Balance Sheet
Total Assets
$152M
Total Liabilities
$228M
Stockholders' Equity
-$76M
Cash & Equivalents
$0
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$0
—
Gross Profit
-$218,000
-$326,000
+33.1%
Operating Income
-$12M
-$20M
+41.3%
Net Income
-$4M
-$20M
+77.7%
← Q4 2016
All Quarters
Q1 2017 →